{"id":"https://openalex.org/W31152949","doi":null,"title":"Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.","display_name":"Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.","publication_year":2003,"publication_date":"2003-03-01","ids":{"openalex":"https://openalex.org/W31152949","mag":"31152949","pmid":"https://pubmed.ncbi.nlm.nih.gov/12661753"},"language":"en","primary_location":{"id":"pmid:12661753","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12661753","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079144385","display_name":"David A. Baker","orcid":"https://orcid.org/0000-0002-5490-8933","observed_orcids":["https://orcid.org/0000-0002-5490-8933"]},"institutions":[{"id":"https://openalex.org/I1327163397","display_name":"State University of New York","ror":"https://ror.org/01q1z8k08","country_code":"US","type":"education","lineage":["https://openalex.org/I1327163397"]},{"id":"https://openalex.org/I4210087560","display_name":"Stony Brook School","ror":"https://ror.org/003wx9n05","country_code":"US","type":"education","lineage":["https://openalex.org/I4210087560"]},{"id":"https://openalex.org/I4210102711","display_name":"Stony Brook Medicine","ror":"https://ror.org/01882y777","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210102711","https://openalex.org/I59553526"]},{"id":"https://openalex.org/I59553526","display_name":"Stony Brook University","ror":"https://ror.org/05qghxh33","country_code":"US","type":"education","lineage":["https://openalex.org/I59553526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Baker","raw_affiliation_strings":["Division of Infectious Diseases, Department of Obstetrics/Gynecology, State University of New York at Stony Brook School of Medicine, 11794-8091, USA. david.baker@stonybrook.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Obstetrics/Gynecology, State University of New York at Stony Brook School of Medicine, 11794-8091, USA. david.baker@stonybrook.edu","institution_ids":["https://openalex.org/I1327163397","https://openalex.org/I4210087560","https://openalex.org/I4210102711","https://openalex.org/I59553526"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065886220","display_name":"Drore Eisen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Drore Eisen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7693,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.84837083,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"71","issue":"3","first_page":"239","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11452","display_name":"Oral Health Pathology and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3500","display_name":"General Dentistry"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valacyclovir","display_name":"valacyclovir","score":1.0},{"id":"https://openalex.org/keywords/recurrent-herpes-labialis","display_name":"recurrent herpes labialis","score":0.8519999980926514},{"id":"https://openalex.org/keywords/herpes-simplex-virus","display_name":"herpes simplex virus","score":0.6890000104904175},{"id":"https://openalex.org/keywords/antiviral-prophylaxis","display_name":"antiviral prophylaxis","score":0.8700000047683716},{"id":"https://openalex.org/keywords/oral-antiviral-therapy","display_name":"oral antiviral therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/acyclovir","display_name":"acyclovir","score":0.8450000286102295},{"id":"https://openalex.org/keywords/recurrence-prevention","display_name":"recurrence prevention","score":0.7799999713897705},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6800000071525574},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9266922473907471},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.9068029522895813},{"id":"https://openalex.org/C2911196830","wikidata":"https://www.wikidata.org/wiki/Q2364836","display_name":"Herpes Labialis","level":4,"score":0.8422830104827881},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6951165795326233},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5307894945144653},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.481989324092865},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.44770342111587524},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.4475848078727722},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41051164269447327},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3535313010215759},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18682023882865906},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08808568120002747},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.07777392864227295},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077483","descriptor_name":"Valacyclovir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006560","descriptor_name":"Herpes Labialis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006560","descriptor_name":"Herpes Labialis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12661753","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12661753","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Clinical Trial"},{"id":"mag:31152949","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12661753","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1453240718","https://openalex.org/W1915846228","https://openalex.org/W1983736207","https://openalex.org/W1987493038","https://openalex.org/W1999799630","https://openalex.org/W2027058673","https://openalex.org/W2031933809","https://openalex.org/W2034906076","https://openalex.org/W2039806594","https://openalex.org/W2069818747","https://openalex.org/W2072501363","https://openalex.org/W2079254561","https://openalex.org/W2089935529","https://openalex.org/W2094190414","https://openalex.org/W2123187222","https://openalex.org/W2315405796","https://openalex.org/W2382308324","https://openalex.org/W2488311271","https://openalex.org/W2510863099","https://openalex.org/W2512337787","https://openalex.org/W2551377048","https://openalex.org/W2554740136","https://openalex.org/W2589011706","https://openalex.org/W2617627106","https://openalex.org/W2618590668","https://openalex.org/W2738995370","https://openalex.org/W2754677493","https://openalex.org/W2769938418","https://openalex.org/W2772605070","https://openalex.org/W2782114914","https://openalex.org/W2789253974","https://openalex.org/W2790153550","https://openalex.org/W2790280697","https://openalex.org/W2795022169","https://openalex.org/W2800156894","https://openalex.org/W2800318697","https://openalex.org/W2801602419","https://openalex.org/W2802876335","https://openalex.org/W2806892205","https://openalex.org/W2884133194","https://openalex.org/W2884539391","https://openalex.org/W2890301830","https://openalex.org/W2896289885","https://openalex.org/W2909069337","https://openalex.org/W2913921289","https://openalex.org/W2918714107","https://openalex.org/W2921566445","https://openalex.org/W2922087160"],"related_works":["https://openalex.org/W120421172","https://openalex.org/W1981644965","https://openalex.org/W3037652263","https://openalex.org/W2370949307","https://openalex.org/W2158661396","https://openalex.org/W7216790875","https://openalex.org/W2031320886","https://openalex.org/W2047006642","https://openalex.org/W7217463265","https://openalex.org/W2049621026"],"abstract_inverted_index":{"The":[0,30,126,145,163,195],"oral":[1,33,59,205],"antiviral":[2],"valacyclovir,":[3],"which":[4],"is":[5,17,214,232],"3":[6],"to":[7,24,54,129,234],"5":[8],"times":[9],"more":[10,86],"bioavailable":[11],"than":[12],"its":[13],"parent":[14],"compound":[15],"acyclovir,":[16],"a":[18,81],"good":[19],"candidate":[20],"for":[21,69,99,211,219],"effective":[22,215],"therapy":[23],"suppress":[25],"recurrent":[26,87,223],"herpes":[27,39,76,224],"labialis":[28,40,77],"lesions.":[29],"efficacy":[31,57],"of":[32,38,58,75,83,148,165,183,193,197,222],"valacyclovir":[34,60,106,136,153,178,206],"in":[35,72,89,104,114,150,159,176],"the":[36,56,73,90,95,105,115,121,169,177,187,220],"suppression":[37,74],"has":[41],"not":[42],"previously":[43],"been":[44],"reported.":[45],"Two":[46],"identical,":[47],"randomized,":[48],"double-blind,":[49,200],"parallel-group":[50],"studies":[51,96,202],"were":[52,97,118],"conducted":[53],"evaluate":[55],"500":[61,207],"mg":[62,208],"(n=49)":[63,66],"versus":[64],"placebo":[65,116,141,188],"once":[67,209],"daily":[68,210],"16":[70],"weeks":[71],"among":[78],"patients":[79,102,112,151,160],"with":[80,109,135,140,157,186,228],"history":[82],"4":[84,212],"or":[85],"lesions":[88],"previous":[91],"year.":[92],"Data":[93],"from":[94],"pooled":[98],"analysis.":[100],"Twenty-eight":[101],"(60%)":[103],"group":[107,117,179,189],"compared":[108,139,156,185],"only":[110],"18":[111],"(38%)":[113],"recurrence-free":[119],"throughout":[120],"4-month":[122,170],"treatment":[123,171],"period":[124,172],"(P=.041).":[125],"mean":[127],"time":[128],"first":[130],"recurrence":[131],"was":[132,154,173],"significantly":[133],"longer":[134],"(13.1":[137],"weeks)":[138,143],"(9.6":[142],"(P=.016).":[144],"total":[146],"number":[147],"recurrences":[149],"using":[152,161],"24":[155],"41":[158],"placebo.":[162],"incidence":[164],"adverse":[166],"events":[167],"during":[168],"slightly":[174],"lower":[175],"(22":[180],"events,":[181,191],"33%":[182],"patients)":[184],"(29":[190],"39%":[192],"patients).":[194],"results":[196],"these":[198,238],"small":[199],"placebo-controlled":[201],"suggest":[203],"that":[204],"months":[213],"and":[216,236],"well":[217],"tolerated":[218],"prevention":[221],"labialis.":[225],"More":[226],"research":[227],"larger":[229],"patient":[230],"numbers":[231],"warranted":[233],"corroborate":[235],"extend":[237],"findings.":[239]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}